SEC Tracker
Get the app
NAII · XBRL financial data

Natural Alternatives International financial statements, every quarter

The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (NAII's year ends in late June)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 25, 2031
Cost of goods and services sold24,81523,21428,070*30,89132,40926,94030,331*33,33332,30435,09932,782*—
Gross profit3871,922—2,2591,6691,826—4,3972,491383——
Research and development——year only———year only———year only—
Selling, general and administrative3,9003,874—4,0954,4493,926—4,1134,3384,397——
Operating income (loss)(3,513)(1,952)(2,525)*(1,836)(2,780)(2,100)(1,944)*284(1,847)(4,014)(13,175)*—
Interest income137976*33415143*300020*—
Other income (expense)(21)2(96)*(1)(3)(8)18*14(64)(9)(2)*—
Income tax expense (benefit)(761)(390)(907)*(431)(675)(456)4,397*922246846*—
Net income (loss)(3,070)(1,578)(1,874)*(1,982)(2,191)(2,186)(7,216)*(291)(2,553)(4,311)(13,540)*—
Earnings per share, basic USD per share(0.52)(0.27)(0.32)*(0.33)(0.37)(0.37)(1.20)*(0.05)(0.42)(0.72)(2.23)*—
Earnings per share, diluted USD per share(0.52)(0.27)(0.32)*(0.33)(0.37)(0.37)(1.20)*(0.05)(0.42)(0.72)(2.23)*—
Weighted average shares, basic thousands of shares5,8505,8685,917*5,9195,9215,9436,004*6,0076,0086,0256,072*—
Weighted average shares, diluted thousands of shares5,8505,8685,917*5,9195,9215,9436,004*6,0076,0086,0256,072*—

Balance sheet

CSV

Fiscal quarters (NAII's year ends in late June)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 25, 2031
Cash and cash equivalents16,59512,40711,98110,1568,66310,61112,3257,7443,7539,1967,388—
Accounts receivable10,45711,22116,89117,62316,89811,65014,64418,91217,76320,58820,650—
Inventory19,59621,07124,24925,92723,03626,99124,87130,65433,43329,93430,753—
Prepaid and other current assets6,4507,6657,9978,7447,9867,7126,7927,5576,2894,1372,580—
Total current assets54,39354,36161,61062,48158,54758,51959,27665,05161,51663,99565,434—
Property and equipment, net53,20752,38452,21151,06050,93950,56450,89050,78851,25850,81335,605—
Right-of-use asset44,99444,03243,53742,91942,30341,68241,05440,42039,77839,13024,062—
Total assets155,733153,211162,342161,270156,128154,944151,939156,945153,301154,880126,446—
Accounts payable7,4946,97012,7409,9458,59712,82115,35220,09516,54518,15618,146—
Accrued liabilities2,0072,4252,8472,7092,2502,1883,1053,7643,6713,3694,601—
Total current liabilities13,41213,64723,46524,43321,64823,31328,80433,90032,84739,12537,717—
Lease liability, non-current46,70145,42346,46846,91045,65945,40545,97045,34944,80044,10428,564—
Total liabilities70,27869,11279,74781,08576,98778,32583,51387,92486,25591,77076,487—
Retained earnings76,41874,84072,96670,98468,79366,60759,39159,10056,54752,23638,696—
Total stockholders' equity85,45584,09982,59580,18579,14176,61968,42669,02167,04663,11049,959—
Total liabilities and equity155,733153,211162,342161,270156,128154,944151,939156,945153,301154,880126,446—
Common shares outstanding (cover page) thousands of shares6,0893,2806,1996,1996,1996,1796,1776,1776,1776,27522,1136,077

Cash flows

CSV

Fiscal quarters (NAII's year ends in late June)

In thousands of dollarsDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026Sep 25, 2031
Net income (loss)(3,070)(1,578)(1,874)*(1,982)(2,191)(2,186)(7,216)*(291)(2,553)(4,311)(13,540)*—
Stock-based compensation305*315*278*276277245179*177178140108*—
Depreciation and amortization1,193*1,098*1,208*1,1271,1341,1391,160*1,1661,1661,1941,183*—
Net cash from operating activities348*(3,624)*(2,717)*(3,443)37*5,993*3,345*(4,023)(6,330)*2,503*(1,066)*—
Purchases of property and equipment429*276*1,034*3011,056*802*1,455*1,030934*1,100*637*—
Net cash from investing activities(429)*(276)*(1,034)*(301)(1,056)*(802)*(1,455)*(1,030)(934)*(1,100)*(637)*—
Share repurchases0*217*4*80*168*2*50*82*2*—
Proceeds from long-term debt——————year only———year only—
Repayments of long-term debt73*71*71*7374*75*74*7478*76*8,766*—
Net cash from financing activities(73)*(288)*3,325*1,919(474)*(3,243)*(176)*4723,273*4,040*(19)*—
Net change in cash(154)*(4,188)*(426)*(1,825)(1,493)*1,948*1,714*(4,581)(3,991)*5,443*(1,722)*—

Compare with peers

SIC 2833 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 2833 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Natural Alternatives International7,388not reported(1,066)*22.1M6.9 quarters 10-KJun 30, 2026
PharmaCyte Biotech17,7390(781)10.7M22.8 quarters 10-QJul 31, 2026
LFTD Partners1,5048,705(555)*14.8M2.7 quarters 10-QJun 30, 2026
Vyome Holdings7,88827(904)*7.0M8.7 quarters 10-QJun 30, 2026
AIM ImmunoTech9,90026(4,590)*30.4M2.2 quarters 10-QJun 30, 2026
Adial Pharmaceuticals28,712not reported(6,363)*2.6M4.5 quarters 10-Q/AJun 30, 2026
Biomerica2,7331,265(802)4.6M3.4 quarters 10-QAug 31, 2026
Protagenic Therapeutics, Inc.\new566not reported(944)1.8M0.6 quarters 10-QJun 30, 2026
Adia Nutrition128485(109)*94.4M1.2 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.